Lyra therapeutics announces $100.5 million private placement

Watertown, mass., april 8, 2022 /prnewswire/ -- lyra therapeutics, inc. (nasdaq: lyra) today announced that it has entered into a securities purchase agreement to sell securities in a private placement that is expected to result in gross proceeds of approximately $100.5 million, before deducting offering expenses.

LYRA Ratings Summary

LYRA Quant Ranking